Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
Phase of Trial: Phase II/III
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Glucagon (Primary) ; Glucagon
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 24 Jul 2019 Results presented in an Eli Lilly media release.
- 14 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 07 Jan 2015 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.